Johnson Investment Counsel’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
56,506
+1,590
+3% +$59.1K 0.02% 325
2026
Q1
$2.2M Sell
54,916
-2,443
-4% -$116K 0.02% 302
2025
Q4
$2.58M Hold
57,359
0.02% 264
2025
Q3
$2.56M Buy
57,359
+240
+0.4% +$11.5K 0.02% 271
2025
Q2
$2.75M Buy
57,119
+519
+0.9% +$22.6K 0.02% 243
2025
Q1
$2.27M Sell
56,600
-119
-0.2% -$5.01K 0.02% 264
2024
Q4
$2.6M Buy
+56,719
New +$2.54M 0.03% 235

Other funds holding QGEN

Johnson Investment Counsel's QGEN Position: Q2 2026 in Review

Johnson Investment Counsel increased its Qiagen (QGEN) stake by 2.9% in Q2 2026, buying an estimated $59.1K and bringing the position to 56,506 shares worth $2.21M. The position accounts for 0.02% of the portfolio, ranked #325.

Johnson Investment Counsel first reported a position in QGEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.75M in Q2 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Johnson Investment Counsel held 56,506 shares of Qiagen worth $2.21M as of Q2 2026.
  • Johnson Investment Counsel bought 1,590 Qiagen shares in Q2 2026, an estimated $59.1K.
  • Qiagen made up 0.02% of Johnson Investment Counsel's portfolio in Q2 2026, its #325 holding.
  • Johnson Investment Counsel first reported a position in Qiagen in Q4 2024 and has held it in 7 quarters since.
  • Johnson Investment Counsel's Qiagen position peaked at $2.75M in Q2 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.